3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
5
Myelodysplastic Syndromes
3
Leukemia, Myelomonocytic, Chronic
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypereosinophilic Syndrome
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
141
Nivolumab
117
Ipilimumab
69
Cyclophosphamide
34
Specimen Handling
30
Magnetic Resonance Spectroscopy
28
trametinib
23
fludarabine
22
binimetinib
22
Interleukin-2
21
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
aldesleukin
16
CTLA-4 Antigen
16
fludarabine phosphate
15
cemiplimab
15
atezolizumab
15
Radiosurgery
15
Opdualag
14
Radiotherapy
11
lifileucel
10
lenvatinib
10
Blood Specimen Collection
10
spartalizumab
8
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
pevonedistat
×
1 year
×
Clear all
No trials found.